Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Eli Lilly to acquire Phase 1/2 DICE Thera for US$2.4 Billion
View:
Post by Noteable on Jul 25, 2023 12:02pm

Eli Lilly to acquire Phase 1/2 DICE Thera for US$2.4 Billion

July 25, 2023 - Eli Lilly has struck a deal with Dice Therapeutics to acquire its early stage treatment portfolio for US$2.4 Billion.

https://www.biospace.com/article/releases/lilly-announces-extension-of-tender-offer-to-acquire-dice/

https://www.dicetherapeutics.com/pipeline/

On July 02, 2023 Eli Lilly announced the acquisition of Sigilon for US$126 per share.

Eli Lilly buys Sigilon for US$126ps which traded at $0.33ps

Sigilon Therapeutics Inc. was trading at US$0.33 per share prior to its 1 for 13 reverse share split on May 22, 2023 that was follwed by Eli Lilly's offer to purchase the company for US$ 126.56 in cash on June 29, 2023 - a price increase of 38,251%.

https://stockhouse.com/companies/bullboard/oncy/oncolytics-biotech-inc?threadid=35524174
Comment by fox7mf on Jul 25, 2023 1:09pm
Yeah, Sigilon got a very healthy buyout. $309.6 million is fantastic for a biotech with only 2.5m shares outstanding. 
Comment by fox7mf on Jul 25, 2023 1:23pm
Dice got $48 per share in the Lilly buyout. They were trading in the low $30 range earlier in 2023. Decent buyout, but yeah Oncy needs to get on creating SH value and 10× todays price pronto. My opinion. 
Comment by Buckhenry on Jul 25, 2023 1:57pm
Wise man says... wish in one hand and poop in the other and see which one fills up first. It's the same ole wait and see and all the dreaming on here ain't going to change that. 
Comment by Noteable on Jul 25, 2023 2:29pm
The reality is that Big Pharma is facing a looming patent cliff which they address by acquiring late-stage de-risked biological assets/companies, like ONCY biological-platform technology in pelareorep,  through premium M&A deals. And Big Pharma has approximately US$1.5 Trillion in "fire-power" to put to work to acquire late-stage biological companies will benefit from the 13 ...more  
Comment by jimsenior on Jul 25, 2023 2:39pm
@Noteable. I too have had enough of that poster. No class. No sense of decency. Nothing.
Comment by Noteable on Jul 25, 2023 3:07pm
Dear jmsenior. Maybe you should have read the post that prompted my response. Or perhaps your criticism is selective, for obvious reasons. On the other hand, I don't care what you think.
Comment by Noteable on Jul 25, 2023 3:09pm
Oh ... sorry jmsenior .. I now see that you were talking about Buckhenry and not about me. Maybe I need stronger reading glasses. Cheers.
Comment by jimsenior on Jul 25, 2023 3:15pm
@Noteable. This means of communicaion is not ideal. What I said was that I have had enough of buck, I thought that was who you were alluding to. How you could rationalize that I was criticizing you or ONC/Y is as befuddling as the share price. If you want a pi$$ing match, I can do that. But it serves no purpose but to let buck rattle the bars.
Comment by jimsenior on Jul 25, 2023 3:16pm
@Noteable. Cheers
Comment by Lesalpes29 on Jul 25, 2023 3:20pm
Jimsenior and Fox you are on the good posters side. Bucky has to be ignored for sure! GL
Comment by Buckhenry on Jul 25, 2023 4:16pm
You dreamers are like the woke movement. You get mad and riot and burn the town down if everyone does not subscribe to your narrative. 99% of the posts on here and stockists and yahoo are rhetoric and have no bearing on this stock. 
Comment by jimsenior on Jul 25, 2023 8:22pm
For those who want to think big on the infinitesimal. Search   -- Beyond the atom  -  incredible plunge into the heart of the matter. Gives scope to the complexities at hand.
Comment by Noteable on Jul 27, 2023 10:21am
Beyond the atom ... Finally! Quantum Mechanics explained in the blink of a wandering eye involving the Higgs field of dark matter. Nice find.
Comment by fox7mf on Jul 25, 2023 3:01pm
Hope that wasn't directed at me. I'm just posting the facts around those buyouts. I, like many others, see a lot of validity behind your $10b-$15b projections for an $Oncy buyout. I actually think there is an argument for an Immunomedics type number...Pela is going to make some BP a lot of $$$$ in many different indications.
Comment by fox7mf on Jul 25, 2023 3:04pm
I have no clue what Buckhenry ever says...I blocked him after the first of his uninformed posts.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities